Balixafortide TFA (1051366-32-5 free base)

Balixafortide TFA (1051366-32-5 free base)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TP2141-5mg 5 mg

7 - 10 business days*

144.00€
TGM-TP2141-25mg 25 mg

7 - 10 business days*

519.00€
TGM-TP2141-50mg 50 mg

7 - 10 business days*

877.00€
TGM-TP2141-100mg 100 mg

7 - 10 business days*

-
TGM-TP2141-200mg 200 mg

7 - 10 business days*

-
 
Description: Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4... more
Product information "Balixafortide TFA (1051366-32-5 free base)"
Description: Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4 antagonist (IC50 < 10 nM). It shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks beta-arrestin recruitment and calcium flux (IC50s < 10 nM). Target: CXCR. References: Zimmermann J, et al. Anti-tumor cell activity and in vitro profile of the next generation CXCR4 antagonist Balixafortide. Ann Oncol. 2018 Oct,29 Suppl 8:viii103.
Keywords: POL6326 TFA, Balixafortide TFA
Supplier: TargetMol
Supplier-Nr: TP2141

Properties

Conjugate: No
MW: 1896.05 D
Formula: C82H113N22F3O23S2

Database Information

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Balixafortide TFA (1051366-32-5 free base)"
Write a review
or to review a product.
Viewed